查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1492409

黏液囊炎治療市場：按類型、藥物類型、最終用戶分類 - 全球預測 2024-2030

Bursitis Treatment Market by Type (Acute Bursitis, Chronic Bursitis), Drug Type (Medication, Physical Therapy), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

黏液囊炎治療市場規模預計到2023年為78.1億美元，2024年達到81.4億美元，預計2030年將達到106.9億美元，複合年成長率為4.58%。

黏液囊炎是一種以發炎或發炎為特徵的疾病，滑囊是關節附近充滿液體的小囊。滑囊可作為緩衝墊，減少骨骼與肌肉、肌腱和皮膚等運動部位之間的摩擦。當這些囊發炎時，受影響的區域會感到疼痛、腫脹和活動受限。黏液囊炎治療是指當滑囊發炎時，黏液囊炎引起的發炎和疼痛的各種方法。關節炎、痛風和糖尿病等肌肉骨骼疾病的增加增加了黏液囊炎的風險。對這種疾病的更好了解和增加醫療基礎設施投資正在促進市場擴張。然而，黏液囊炎的症狀往往與其他關節疾病相似，這可能導致誤診和治療無效。此外，新興國家正在發展醫療基礎設施，為黏液囊炎治療創造了新的市場。診斷工具和治療方案的改進可以帶來更有效、更快的結果，從而增加市場成長機會。

主要市場統計
基準年[2023] 78.1億美元
預測年份 [2024] 81.4億美元
預測年份 [2030] 106.9億美元
複合年成長率（%） 4.58%

區域洞察

美國肌肉骨骼疾病的盛行率很高，是黏液囊炎治療的重要市場。先進的醫療基礎設施、對該疾病的廣泛認知以及積極參與導致運動傷害的運動，導致對有效治療的需求不斷成長。該市場的特點是存在大量投資於研發的大型製藥企業。美國正在進行的創新主要集中在新型發炎藥物和微創外科手術上，以確保更快的康復和更少的副作用。在歐盟國家，人口老化和運動的普及正在創造對黏液囊炎治療的強勁需求。整個歐盟的醫療保健法規和政策強調安全有效的治療，將研究引向更安全的藥物干預和物理治療技術。歐盟資助的計劃通常著重於在更廣泛的健康舉措下改善肌肉骨骼疾病（包括黏液囊炎）的診斷和治療。中東治療市場正在成長，並受到醫療設施改善和可支配收入增加的影響。亞太地區人口眾多且老年人口不斷增加，是黏液囊炎治療的一個值得注意的市場。政府對醫療改革和提高老齡化社會生活品質的支持正在刺激研究和發展。

FPNV定位矩陣

FPNV 定位矩陣對於評估黏液囊炎治療市場供應商的市場定位至關重要。此矩陣提供了對供應商的全面評估，並檢查了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對黏液囊炎治療市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭性質的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對黏液囊炎治療市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球肌肉骨骼疾病的發生率正在增加
      • 提高對衛生基礎設施的認知和投資
    • 抑制因素
      • 政府對藥品核准的嚴格規定
    • 機會
      • 黏液囊炎診斷工具和治療方案的進展
      • 藥物研發配方持續創新
    • 任務
      • 診斷複雜且缺乏報銷政策
  • 市場區隔分析
    • 類型：慢性黏液囊炎有利於解決疼痛管理和預防進一步關節損傷的治療
    • 最終使用者：醫院和診所可以輕鬆獲得急性黏液囊炎所需的即時治療。
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章黏液囊炎治療市場：依類型

  • 急性黏液囊炎
  • 慢性黏液囊炎

第7章依藥物類型分類的黏液囊炎治療市場

  • 藥物治療
  • 物理治療

第8章黏液囊炎治療市場：依最終用戶分類

  • 醫院/診所
  • 復健中心

第9章北美和南美黏液囊炎治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太黏液囊炎治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的黏液囊炎治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 遠藤製藥推出非專利藥 Duexis“Ibuprofen/法莫替丁片”
    • FDA核准創新皮質類固醇治療Duchenne氏肌肉失養症
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-5D693B46C73C

[195 Pages Report] The Bursitis Treatment Market size was estimated at USD 7.81 billion in 2023 and expected to reach USD 8.14 billion in 2024, at a CAGR 4.58% to reach USD 10.69 billion by 2030.

Bursitis is a medical condition characterized by inflammation or irritation of a bursa, which is a small fluid-filled sac located near the joints. Bursae function as cushions, reducing friction between the bones and other moving parts, including muscles, tendons, and skin. When these sacs become inflamed, the affected area can experience pain, swelling, and restricted movement. Bursitis treatment refers to the various methods used to loosen the inflammation and pain caused by bursitis, a condition where the bursae become inflamed. Increases in the incidence of musculoskeletal disorders, including arthritis, gout, and diabetes, escalate the risk of developing bursitis. Enhanced understanding of the condition and greater investment in health infrastructure contribute to market expansion. However, bursitis symptoms often mimic those of other joint disorders, potentially leading to misdiagnosis and ineffective treatments. Furthermore, developing regions are observing increased healthcare infrastructure, presenting new markets for bursitis treatments. Improved diagnostic tools and treatment options enhance market growth opportunities by providing more effective and faster results.

KEY MARKET STATISTICS
Base Year [2023] USD 7.81 billion
Estimated Year [2024] USD 8.14 billion
Forecast Year [2030] USD 10.69 billion
CAGR (%) 4.58%

Regional Insights

The United States is a significant market for bursitis treatment due to a high prevalence of musculoskeletal conditions. Advanced healthcare infrastructure, widespread awareness about the condition, and active participation in sports leading to sports injuries contribute to a higher demand for effective treatments. The market is characterized by the presence of leading pharmaceutical companies investing heavily in research and development. Ongoing innovation in the United States focuses on novel anti-inflammatory drugs and minimally invasive surgical procedures that promise faster recovery and fewer side effects. EU countries show a strong demand for bursitis treatments driven by an aging population and a high rate of sports activities. Regulations and healthcare policies across the EU emphasize safe and effective treatments, steering research towards safer pharmacological interventions and physiotherapy techniques. EU-funded projects often focus on improving diagnosis and treatments for musculoskeletal disorders, including bursitis, under broader health initiatives. The treatment market in the Middle East is growing and is influenced by improving healthcare facilities and increasing disposable incomes. APAC, with a large population and increasing elderly demographic, makes it a noteworthy market for bursitis treatments. The government's push towards healthcare reform and enhancing the quality of life for the aging population has fueled research and development.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Bursitis Treatment Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising incidence of musculoskeletal disorders globally
      • Increased awareness coupled with rising investment in health infrastructure
    • Market Restraints
      • Strict government regulations regarding drug approval
    • Market Opportunities
      • Advancements in diagnostic tools and treatment options in bursitis
      • Ongoing innovation in drug development formulations
    • Market Challenges
      • Complexities associated with diagnostic and lack of reimbursement policies
  • Market Segmentation Analysis
    • Type: Chronic bursitis prefer treatments to address pain management and prevention of further joint damage
    • End-User: Hospitals and clinics offer better accessibility for the immediate care required for acute bursitis
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Bursitis Treatment Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Bursitis Treatment Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Endo Pharmaceuticals Introduces Generic Version of Duexis: Ibuprofen-Famotidine Tablets

Endo Pharmaceuticals has launched a new generic medication containing ibuprofen and famotidine, which serves as a counterpart to the branded drug Duexis. This new generic product is specifically formulated to simultaneously alleviate pain and reduce the risk of stomach ulcers, addressing the dual needs of patients who require nonsteroidal anti-inflammatory drugs (NSAIDs) for conditions such as bursitis while safeguarding their gastrointestinal health. [Published On: 2024-03-26]

FDA Greenlights Innovative Corticosteroid for Duchenne Muscular Dystrophy Management

The U.S. Food and Drug Administration (FDA) has approved a new corticosteroid treatment for patients with Duchenne Muscular Dystrophy (DMD). This novel therapeutic option is designed to provide the benefits of traditional corticosteroid therapy but with reduced adverse effects. This approval marks a significant advancement in managing DMD, offering a more tolerable and potentially effective treatment alternative. [Published On: 2023-10-27]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Bursitis Treatment Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Bursitis Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amgen Inc., Arinna Lifesciences Ltd., AstraZeneca PLC, Bioanalytical Systems, Inc., Bristol-Myers Squibb Company, Crescent Formulations Pvt.Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., NIDEK CO., LTD., Novartis AG, Perrigo Company PLC, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., and Topcon Corporation.

Market Segmentation & Coverage

This research report categorizes the Bursitis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Acute Bursitis
    • Chronic Bursitis
  • Drug Type
    • Medication
      • Corticosteroids
      • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • Physical Therapy
    • Physical Therapy
  • End-User
    • Hospitals & Clinics
    • Rehabilitation Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of musculoskeletal disorders globally
      • 5.1.1.2. Increased awareness coupled with rising investment in health infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Strict government regulations regarding drug approval
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in diagnostic tools and treatment options in bursitis
      • 5.1.3.2. Ongoing innovation in drug development formulations
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities associated with diagnostic and lack of reimbursement policies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Chronic bursitis prefer treatments to address pain management and prevention of further joint damage
    • 5.2.2. End-User: Hospitals and clinics offer better accessibility for the immediate care required for acute bursitis
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Bursitis Treatment Market, by Type

  • 6.1. Introduction
  • 6.2. Acute Bursitis
  • 6.3. Chronic Bursitis

7. Bursitis Treatment Market, by Drug Type

  • 7.1. Introduction
  • 7.2. Medication
  • 7.3. Physical Therapy

8. Bursitis Treatment Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
  • 8.3. Rehabilitation Centers

9. Americas Bursitis Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bursitis Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bursitis Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Endo Pharmaceuticals Introduces Generic Version of Duexis: Ibuprofen-Famotidine Tablets
    • 12.3.2. FDA Greenlights Innovative Corticosteroid for Duchenne Muscular Dystrophy Management
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BURSITIS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. BURSITIS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BURSITIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BURSITIS TREATMENT MARKET DYNAMICS
  • FIGURE 7. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. BURSITIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. BURSITIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BURSITIS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BURSITIS TREATMENT MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BURSITIS TREATMENT MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ACUTE BURSITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ACUTE BURSITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CHRONIC BURSITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CHRONIC BURSITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. AUSTRALIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. AUSTRALIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 100. AUSTRALIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 102. AUSTRALIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 103. CHINA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. CHINA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. CHINA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. CHINA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. CHINA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 108. CHINA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 109. CHINA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 110. CHINA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 111. INDIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. INDIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. INDIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. INDIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. INDIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 116. INDIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 117. INDIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. INDIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. INDONESIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. INDONESIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. INDONESIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. INDONESIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. INDONESIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 124. INDONESIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 125. INDONESIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 126. INDONESIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 127. JAPAN BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. JAPAN BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. JAPAN BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. JAPAN BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. JAPAN BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 132. JAPAN BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 133. JAPAN BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. JAPAN BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. MALAYSIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. MALAYSIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. MALAYSIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. MALAYSIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. MALAYSIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 140. MALAYSIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 141. MALAYSIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. MALAYSIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. PHILIPPINES BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. PHILIPPINES BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 148. PHILIPPINES BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. PHILIPPINES BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. SINGAPORE BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. SINGAPORE BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. SINGAPORE BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. SINGAPORE BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. SINGAPORE BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 156. SINGAPORE BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 157. SINGAPORE BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 158. SINGAPORE BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 159. SOUTH KOREA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. SOUTH KOREA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. SOUTH KOREA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 164. SOUTH KOREA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH KOREA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. TAIWAN BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. TAIWAN BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. TAIWAN BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. TAIWAN BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. TAIWAN BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 172. TAIWAN BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 173. TAIWAN BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. TAIWAN BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. THAILAND BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. THAILAND BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. THAILAND BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. THAILAND BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. THAILAND BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 180. THAILAND BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 181. THAILAND BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 182. THAILAND BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 183. VIETNAM BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. VIETNAM BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. VIETNAM BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. VIETNAM BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. VIETNAM BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 188. VIETNAM BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 189. VIETNAM BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. VIETNAM BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 201. DENMARK BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. DENMARK BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. DENMARK BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. DENMARK BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. DENMARK BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 206. DENMARK BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 207. DENMARK BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 208. DENMARK BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 209. EGYPT BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. EGYPT BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. EGYPT BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. EGYPT BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. EGYPT BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 214. EGYPT BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 215. EGYPT BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. EGYPT BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. FINLAND BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. FINLAND BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. FINLAND BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. FINLAND BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. FINLAND BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 222. FINLAND BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 223. FINLAND BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 224. FINLAND BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 225. FRANCE BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. FRANCE BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. FRANCE BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. FRANCE BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. FRANCE BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 230. FRANCE BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 231. FRANCE BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 232. FRANCE BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 233. GERMANY BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. GERMANY BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. GERMANY BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. GERMANY BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. GERMANY BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 238. GERMANY BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 239. GERMANY BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. GERMANY BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. ISRAEL BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. ISRAEL BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. ISRAEL BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. ISRAEL BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. ISRAEL BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 246. ISRAEL BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 247. ISRAEL BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 248. ISRAEL BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 249. ITALY BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. ITALY BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. ITALY BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. ITALY BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. ITALY BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 254. ITALY BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 255. ITALY BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. ITALY BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. NETHERLANDS BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. NETHERLANDS BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. NETHERLANDS BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 262. NETHERLANDS BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 264. NETHERLANDS BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 265. NIGERIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. NIGERIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. NIGERIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. NIGERIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. NIGERIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 270. NIGERIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 271. NIGERIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 272. NIGERIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 273. NORWAY BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. NORWAY BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. NORWAY BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. NORWAY BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. NORWAY BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 278. NORWAY BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 279. NORWAY BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 280. NORWAY BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 281. POLAND BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. POLAND BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. POLAND BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. POLAND BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. POLAND BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 286. POLAND BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 287. POLAND BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 288. POLAND BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 289. QATAR BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 290. QATAR BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 291. QATAR BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 292. QATAR BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 293. QATAR BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 294. QATAR BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 295. QATAR BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 296. QATAR BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 297. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 298. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 299. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 302. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 303. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 304. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 305. SAUDI ARABIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 306. SAUDI ARABIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. SAUDI ARABIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 310. SAUDI ARABIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 312. SAUDI ARABIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 313. SOUTH AFRICA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. SOUTH AFRICA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 316. SOUTH AFRICA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 318. SOUTH AFRICA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 320. SOUTH AFRICA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 321. SPAIN BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 322. SPAIN BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 323. SPAIN BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 324. SPAIN BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 325. SPAIN BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 326. SPAIN BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 327. SPAIN BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 328. SPAIN BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 329. SWEDEN BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 330. SWEDEN BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 331. SWEDEN BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 332. SWEDEN BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 333. SWEDEN BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 334. SWEDEN BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 335. SWEDEN BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 336. SWEDEN BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 337. SWITZERLAND BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 338. SWITZERLAND BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 339. SWITZERLAND BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 340. SWITZERLAND BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 342. SWITZERLAND BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 344. SWITZERLAND BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 345. TURKEY BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 346. TURKEY BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 347. TURKEY BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 348. TURKEY BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 349. TURKEY BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 350. TURKEY BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 351. TURKEY BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 352. TURKEY BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 353. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 354. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 355. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 356. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 357. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 360. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 361. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 362. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 363. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 364. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 365. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 366. U